Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: Local immunosuppression or islet toxicity

Transplantation

Volumn 76, Issue 11, 2003, Pages 1623-1625

  Desai, Niraj M ^a   Goss, John A ^b   Deng, Shaoping ^c   Wolf, Bryan A ^d   Markmann, Eileen ^c   Palanjian, Maral ^c   Shock, Angela P ^c   Feliciano, Sue ^b   Brunicardi, F Charles ^b   Barker, Clyde F ^c   Naji, Ali ^c   Markmann, James F ^c,e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; TACROLIMUS;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG BLOOD LEVEL; DRUG EFFECT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PANCREAS ISLET TRANSPLANTATION; PORTAL VEIN BLOOD; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; TREATMENT PLANNING; UNITED STATES; VENOUS BLOOD;

HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; PORTAL SYSTEM; PORTAL VEIN; REGRESSION ANALYSIS; SIROLIMUS;

EID: 10744230856     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000081043.23751.81     Document Type: Article

References (8)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Tyden G, Reinholt FP, Sundkvist G, et al. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 1996; 335: 860.
3. Tamura K, Fujimura T, Tsutsumi T, et al. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic β-cell. Transplantation 1995; 59: 1606.
4. Ricordi C, Zeng Y, Alejandro R, et al. In vivo effect of FK506 on human pancreatic islets. Transplantation 1991; 52: 519.
5. Bell E, Cao X, Gao Z, et al. The deleterious effect of rapamycin on beta cells and islets. Diabetes 2002; 51(S): A459.
6. Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor. Nat Med 2002; 8: 128.
7. Shapiro AMJ, Gallant H, Hao E, et al. Portal vein immunosuppressant levels and islet graft toxicity. Transplant Proc 1998; 30: 641.
8. Andersson KE, Nyberg L, Dencker H, et al. Absorption of digoxin in man after oral and intrasigmoid administration studied by portal vein catheterization. Eur J Clin Pharmacol 1975; 9: 39.